enrasentan has been researched along with Hypertrophy, Right Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelberts, D; Jankov, RP; Kantores, C; Kavanagh, BP; McNamara, PJ; Murthy, P; Teixeira, L | 1 |
| Bochnowicz, S; Elliott, JD; Hart, TK; Hay, DW; Louden, CS; Luttmann, MA; Osborn, RR; Underwood, DC | 1 |
2 other study(ies) available for enrasentan and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat.
Topics: Animals; Animals, Newborn; Body Weight; Carbon Dioxide; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Female; Hematocrit; Hypercapnia; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Oxidative Stress; Oxygen; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Rats; Up-Regulation | 2006 |
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Topics: Altitude; Animals; Benzofurans; Carboxylic Acids; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indans; Male; Propionates; Pulmonary Artery; Pyrrolidines; Random Allocation; Rats; Receptors, Endothelin | 1999 |